Physiol. Genomics Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Physiol. Genomics (May 26, 2009). doi:10.1152/physiolgenomics.00011.2009 Free Article
This Article
Free upon publication Free Article
Right arrow Full Text (PDF)
Right arrow Supplemental Figures and Tables
Right arrow All Versions of this Article:
38/2/226    most recent
00011.2009v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Vogel, H.
Right arrow Articles by Scherneck, S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vogel, H.
Right arrow Articles by Scherneck, S.
Submitted on January 16, 2009
Revised on May 18, 2009
Accepted on May 22, 2009

Characterisation of Nob3, a major quantitative trait locus for obesity and hyperglycaemia on mouse Chromosome 1

Heike Vogel1, Matthias Nestler1, Franz Rüschendorf2, Marcel-Dominique Block1, Sina Tischer1, Reinhart Kluge3, Annette Schurmann4, Hans-Georg Joost1*, and Stephan Scherneck1

1 German Institute of Human Nutrition Potsdam-Rehbruecke
2 Max Delbrück Centre for Molecular Medicine, Berlin-Buch
3 German Institute of Huyman Nutrition
4 German Institute of Human Nutrition

* To whom correspondence should be addressed. E-mail: joost{at}dife.de.

New Zealand obese (NZO) mice present a metabolic syndrome of obesity, insulin resistance, and diabetes. In order to identify chromosomal segments associated with these traits, we intercrossed NZO mice with the lean and diabetes-resistant C57BL/6J (B6) strain. Obesity and hyperglycaemia in the (NZOxB6)F2 intercross population were predominantly due to a broad QTL on Chromosome 1 (Nob3; LOD score 16.1, 16.0, 4.0 for body weight, body fat, and blood glucose, respectively), producing a difference between genotypes of 12.7 or 5.2 g of body weight and 12.0 or 4.0 g of body fat in females or males, respectively. In addition, significant QTL on Chromosomes 3 and 13, suggestive QTL on Chromosomes 4, 6, 9, 12, 14, and 19 contributed to the obese phenotype. Distal Chromosome 5 was significantly linked with plasma cholesterol (LOD score 10.7). Introgression of two segments of Nob3 into B6 confirmed the adipogenic effect of the QTL and suggested the presence of at least one causal gene. Haplotype mapping reduced the critical region of the distal part of the QTL to 31 Mbp containing the potential candidates Nr1i3, Apoa2, Atp1a2, Prox1, and Hsd11b1. We conclude that obesity and hyperglycaemia of NZO is to a large part caused by variant genes located in Nob3 on Chromosome 1. Since these exert robust effects on a B6 background, the QTL Nob3 is a prime target for identification of a novel diabesity gene.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.